Form 4: Exact Sciences Director Daniel Levangie Sells 5,000 Shares

Director Daniel Levangie of Exact Sciences Corp. sold 5,000 shares of common stock on March 1, 2024, at a price of $57.50 per share.

Summary

• On March 1, 2024, Daniel J. Levangie, a director of Exact Sciences Corp., sold 5,000 shares of the company's common stock.
• The sale was executed at a price of $57.50 per share.
• Following the transaction, Levangie directly owns 22,975 shares of Exact Sciences Corp.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan established on November 6, 2023.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by a company director under a pre-arranged trading plan, which is neither particularly positive nor negative.

Industry Context

Sales by company directors are a normal part of corporate governance. It is important to consider the context of the sale, such as the Rule 10b5-1 trading plan, which allows insiders to sell shares at predetermined times to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a Rule 10b5-1 plan mitigates concerns about insider trading.

Key Dates